Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000263328

Medchemexpress LLC N-(4-(N-(3,4-dimethylisoxazol-5-yl)sulfamoyl)phenyl)-6,8-dimethyl-2-(2-pyridyl)quinoline-4-carboxamide | 713121-80-3 | MFCD05999971 | 99.8% | 527.59 g/mol | C28H25N5O4S | 5 MG
SDP

Catalog No. 5000263328
Encompass_Preferred

ML-193 is a research-grade small-molecule antagonist of the GPR55 receptor (CAS 713121-80-3), provided as a characterized solid for cellular and biochemical studies. It has a defined molecular formula and reported high purity for laboratory use.

  • High purity (99.82%) suitable for research applications.
  • Solid form simplifies handling and long-term storage.
  • Molecular formula C28H25N5O4S and molecular weight 527.59 g/mol.
  • Recommended storage: powder -20°C (up to 3 years) or 4°C (up to 2 years).
  • Stable in solvent when stored at -80°C for up to 6 months.

Catalog No. 50-002-63328 Supplier Medchemexpress LLC Supplier No. HY1101255MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ML-193 is a research-grade small-molecule antagonist of the GPR55 receptor (CAS 713121-80-3), provided as a characterized solid for cellular and biochemical studies. It has a defined molecular formula and reported high purity for laboratory use.

  • High purity (99.82%) suitable for research applications.
  • Solid form simplifies handling and long-term storage.
  • Molecular formula C28H25N5O4S and molecular weight 527.59 g/mol.
  • Recommended storage: powder -20°C (up to 3 years) or 4°C (up to 2 years).
  • Stable in solvent when stored at -80°C for up to 6 months.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.